Testosterone Cypionate Should NOT Be Taken Orally
Testosterone cypionate is formulated exclusively for intramuscular injection and must never be administered orally—this route is both ineffective and potentially dangerous. 1
Why Oral Administration is Contraindicated
FDA-Approved Route of Administration
- The FDA label for testosterone cypionate explicitly states it is "for intramuscular use only" and "should not be given intravenously" 1
- The formulation is designed as an oil-based injectable preparation specifically for deep gluteal intramuscular injection 1
- There is no approved oral formulation of testosterone cypionate available in the United States 1
Hepatotoxicity Concerns with Oral Testosterone
- Oral preparations of testosterone have been reported to cause severe hepatotoxic effects and neoplasia, including both benign and malignant liver tumors 2
- The New England Journal of Medicine explicitly states: "The use of oral forms of testosterone in the United States is strongly discouraged because of the associated hepatotoxicity" 2
- Routine liver function monitoring is unnecessary for intramuscular and transdermal preparations precisely because they bypass first-pass hepatic metabolism 2
Pharmacokinetic Failure
- Standard testosterone formulations like testosterone cypionate undergo rapid first-pass hepatic metabolism when taken orally, rendering them therapeutically ineffective 3
- While experimental research has explored oral testosterone in oil with dutasteride co-administration, this remains investigational and is not clinically available or approved 3
- Testosterone undecanoate is the only oral testosterone preparation that avoids significant hepatotoxicity, but it is not available in the United States 2
Approved Testosterone Formulations
Injectable Options (Recommended for Testosterone Cypionate)
- Testosterone cypionate: 100-200 mg intramuscularly every 2 weeks or 50 mg weekly 2
- Advantages: relatively inexpensive, flexible dosing, no risk of transference to others 2
- Disadvantages: requires intramuscular injection, fluctuating serum levels with peaks and valleys 2
Alternative Routes if Injections Are Not Feasible
- Transdermal gels (AndroGel, Testim, Fortesta): 50-100 mg daily applied to skin 2
- Transdermal patches (Androderm): 2-6 mg/24 hours 2
- Buccal tablets (Striant): 30 mg twice daily applied to gum 2
- Subcutaneous pellets (Testopel): 150-450 mg every 3-6 months 2
Critical Safety Warning
Attempting to create an oral "mix" of testosterone cypionate poses serious risks:
- No therapeutic benefit due to rapid hepatic metabolism
- Potential for severe liver damage and hepatic tumors 2
- Risk of improper dosing and adverse effects
- Violation of FDA-approved administration routes 1
Clinical Bottom Line
If intramuscular injections are not acceptable to the patient, switch to an FDA-approved alternative formulation (transdermal gel, patch, or buccal tablet) rather than attempting oral administration of an injectable product 2. The transdermal preparations are generally recommended as first-line alternatives because they produce stable serum testosterone concentrations and are convenient for most patients 2.